Advice
In the absence of a submission from the holder of the marketing authorisation.
epinastine (Relestal) is not recommended for use within NHS Scotland for the treatment of the symptoms of seasonal allergic conjunctivitis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- epinastine (Relestal)
- SMC ID:
- 267/06
- Indication:
- Seasonal allergic conjunctivitis
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Eye
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 May 2006